Quick Heal Technologies Ltd. (IN:QUICKHEAL)
:QUICKHEAL
Want to see IN:QUICKHEAL full AI Analyst Report?
Top Page
Quick Heal Technologies Ltd.
(QUICKHEAL)
Select Model
Select Model
Rating:45Neutral
Price Target:
₹162.00
▼(-39.73% Downside)
Action:ReiteratedDate:03/19/26
The score is pressured primarily by deteriorating financial performance (negative operating profitability and negative operating/free cash flow in FY2025) and bearish technicals (price below all major DMAs with negative MACD). A strong, low-debt balance sheet is the key stabilizer, but high valuation (P/E ~54.5) offers limited downside support.
Positive Factors
Balance Sheet Strength
Low leverage and sizable equity give the company durable financial flexibility. This conservatism supports funding R&D, sustaining operations through cyclical softness, and optionality for targeted M&A or strategic spending without immediate refinancing pressure, aiding multi‑month resilience.
Negative Factors
Revenue Decline & Operating Weakness
A falling top line and a shift to negative operating profitability indicate loss of demand and deteriorated operating leverage. This undermines sustainable earnings and limits reinvestment capacity, creating a multi‑month challenge to restore growth and durable margin recovery.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
Low leverage and sizable equity give the company durable financial flexibility. This conservatism supports funding R&D, sustaining operations through cyclical softness, and optionality for targeted M&A or strategic spending without immediate refinancing pressure, aiding multi‑month resilience.
Read all positive factors
Quick Heal Technologies Ltd. (QUICKHEAL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹9.02B
Dividend Yield1.08%
Average Volume (3M)72.37K
Price to Earnings (P/E)54.5
Beta (1Y)1.78
Revenue Growth-5.77%
EPS Growth-74.64%
CountryIN
Employees996
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)1.22
Shares Outstanding54,245,457
10 Day Avg. Volume143,023
30 Day Avg. Volume72,369
Financial Highlights & Ratios
PEG Ratio-4.13
Price to Book (P/B)3.74
Price to Sales (P/S)5.91
P/FCF Ratio-45.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Quick Heal Technologies Ltd. Business Overview & Revenue Model
Company Description
Quick Heal Technologies Limited provides security software products and solutions to consumers, small businesses, government establishments, and corporate houses in India and internationally. The company operates through Retail, Enterprise and Gov...
How the Company Makes Money
Quick Heal Technologies makes money primarily by selling cybersecurity software and related services under its consumer (Quick Heal) and enterprise (Seqrite) product lines. Key revenue streams generally include: (1) consumer cybersecurity licenses...
Quick Heal Technologies Ltd. Financial Statement Overview
Summary
Income Statement
41
Neutral
Balance Sheet
86
Very Positive
Cash Flow
33
Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.77B | 2.80B | 2.92B | 2.78B | 3.42B | 3.33B |
| Gross Profit | 2.72B | 2.72B | 1.17B | 1.14B | 1.92B | 2.04B |
| EBITDA | 78.90M | -65.90M | 373.00M | 227.70M | 1.07B | 1.45B |
| Net Income | -7.40M | 50.40M | 242.40M | 64.00M | 831.90M | 1.07B |
Balance Sheet | ||||||
| Total Assets | 5.45B | 5.25B | 5.13B | 4.93B | 7.16B | 8.27B |
| Cash, Cash Equivalents and Short-Term Investments | 1.85B | 1.93B | 2.20B | 1.88B | 3.54B | 4.67B |
| Total Debt | 0.00 | 3.10M | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 988.80M | 835.60M | 756.30M | 735.90M | 882.50M | 752.10M |
| Stockholders Equity | 4.46B | 4.41B | 4.37B | 4.20B | 6.28B | 7.51B |
Cash Flow | ||||||
| Free Cash Flow | -189.90M | -367.20M | 106.30M | 267.30M | 741.30M | 897.60M |
| Operating Cash Flow | -54.30M | -223.00M | 181.90M | 308.10M | 799.80M | 986.20M |
| Investing Cash Flow | -102.90M | 159.70M | 61.50M | 1.85B | 1.26B | -922.90M |
| Financing Cash Flow | 16.20M | -103.20M | 16.00M | -2.12B | -2.14B | 1.00M |
Quick Heal Technologies Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹12.21B | 38.21 | ― | 0.55% | 15.77% | -51.67% | |
68 Neutral | ₹18.82B | 21.87 | ― | 0.42% | 19.12% | 24.14% | |
65 Neutral | ₹22.65B | 84.78 | ― | ― | 123.77% | 946.70% | |
64 Neutral | ₹19.19B | 1.71 | ― | ― | 29.92% | 39.48% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | ₹5.25B | 56.55 | ― | ― | -7.40% | ― | |
45 Neutral | ₹9.02B | 54.49 | ― | 1.08% | -5.77% | -74.64% |
* Technology Sector Average
IN:QUICKHEAL
Quick Heal Technologies Ltd.
166.25
-108.85
-39.57%
IN:BCG
Brightcom Group Limited
9.51
-0.77
-7.49%
IN:IKIO
IKIO Lighting Limited
157.95
-63.30
-28.61%
IN:KERNEX
Kernex Microsystems India Ltd.
1,347.80
600.20
80.28%
IN:SAKSOFT
Saksoft Limited
142.00
-12.01
-7.80%
IN:SUBEXLTD
Subex Limited
9.35
-2.01
-17.69%
Quick Heal Technologies Ltd. Corporate Events
Quick Heal Allots 2,261 ESOP Shares, Slightly Expands Equity Base
Apr 27, 2026
Quick Heal Technologies has allotted 2,261 equity shares under its ESOP Scheme 2021 following the exercise of employee stock options, marginally increasing its total issued equity share capital. The new shares, issued at various exercise prices wi...
Quick Heal Closes Trading Window Ahead of FY 2026 Results
Mar 23, 2026
Quick Heal Technologies Limited has announced that its trading window for dealing in the company’s securities will be closed from April 1, 2026, in line with SEBI’s Prohibition of Insider Trading Regulations, 2015, and its internal cod...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.